THE ISSUE OF LEGALIZING CANNABIS: A QUALITATIVE ANALYSIS OF THE STUDENT’S PUBLIC DISCOURSE
-
Published:2024-04-08
Issue:4
Volume:12
Page:e3476
-
ISSN:2764-4170
-
Container-title:Journal of Law and Sustainable Development
-
language:
-
Short-container-title:J. of Law and Sust. Develop.
Abstract
Introduction: The objective of the present work is to analyze in a multidimensional view, Albania's Law No. 61/2023 on Cannabis legalization for its legal, applicability mechanisms, and economic challenges, assessing the readiness of the country, clarity, and impact on drug control.
Method: The method of this study is quasi-experimental, and it is divided into two phases.
The current study sample is two hundred students, of whom 120 (60%) were from the Faculty of Law and 80 (40%) from the University of Medical Sciences. The initial retrospective study (T1) was employed to identify the gaps in the legal education of law and assess the legislation’s stance. Five months later (T2) Medical Cannabis Juridical Education; Law enforcement capacities; and Social and Psychological impact identified as the key gaps were evaluated.
Results: The students enrolled in the Law and Pharmacy program showed an improved understanding of the socio-psychological ramifications associated with the law implementation in Albania (t1 = 2; 7; t2 = 3.76; p < 0.001). Regressive results revealed an influence of Judicial and Psychoeducational training on the students' public opinion with an R-value model summary of 0,706 (70%).
Conclusions: The findings of this study suggest that the legalization of Cannabis in Albania is a significant challenge for the country and continued follow-up and public training would increase public awareness and assertiveness toward the Law.
Publisher
South Florida Publishing LLC
Reference47 articles.
1. Allen, J., Lee, Y. O., Woodlea, R., Malo, V. F., & Zitney, L. V. (2023). Public education can be used to increase support for equity in cannabis policy. Cannabis. https://doi.org/10.26828/cannabis/2023/000146 2. Amin, R., & Ali, D. W. (2019). Pharmacology of medical cannabis. In Advances in Experimental Medicine and Biology (pp. 151–165). https://doi.org/10.1007/978-3-030-21737-2_8 3. Asphianto, A. (2024). APPLICATION OF LAW NUMBER 35 OF 2009 CONCERNING NARCOTICS; CASE STUDY OF DECISIONS IN SERANG DISTRICT COURT. Journal of Law and Sustainable Development, 12(3), e3455. https://doi.org/10.55908/sdgs.v12i3.3455 4. Black, M. D., Stevens, R. J., Rogacki, N., Featherstone, R. E., Senyah, Y., Giardino, O. Z., Borowsky, B., Stemmelin, J., Cohen, C., Pichat, P., Arad, M., Barak, S., De Levie, A., Weiner, I., Griebel, G., & Varty, G. B. (2010). AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. Psychopharmacology, 215(1), 149–163. https://doi.org/10.1007/s00213-010-2124-0 5. Blanco, C., Hasin, D. S., Wall, M. M., Flórez‐Salamanca, L., Hoertel, N., Wang, S., Kerridge, B. T., & Olfson, M. (2016). Cannabis use and risk of psychiatric disorders. JAMA Psychiatry, 73(4), 388. https://doi.org/10.1001/jamapsychiatry.2015.3229
|
|